Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer (2017)
- Authors:
- USP affiliated authors: TIEZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP
- Unidade: FMRP
- DOI: 10.1001/jamaoncol.2017.3290
- Subjects: NEOPLASIAS OVARIANAS; CITOTOXICIDADE IMUNOLÓGICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: JAMA Oncology
- ISSN: 2374-2437
- Volume/Número/Paginação/Ano: v. 3, n. 12, dec., art.e173290, 2017
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
GOODE, Ellen L. et al. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, v. 3, n. 12, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaoncol.2017.3290. Acesso em: 31 mar. 2026. -
APA
Goode, E. L., Sousa, C. B. de, Tiezzi, D. G., Andrade, J. M. de, & Reis, F. J. C. dos. (2017). Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, 3( 12). doi:10.1001/jamaoncol.2017.3290 -
NLM
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2026 mar. 31 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290 -
Vancouver
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2026 mar. 31 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290 - Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
- Impacto prognóstico da recorrência local em pacientes com câncer inicial de mama submetidas a tratamento conservador
- Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Idade como fator independente de prognóstico no câncer de mama
- Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort
- Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
